HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
12
|
52
|
0.100 |
None |
|
0 |
1
|
|
|
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.400 |
None |
0.960 |
99 |
|
1996 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.070 |
None |
1.000 |
7 |
|
1997 |
2017 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.100 |
None |
1.000 |
37 |
|
1999 |
2019 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.100 |
None |
1.000 |
33 |
|
1999 |
2019 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.100 |
None |
1.000 |
22 |
|
1999 |
2019 |
Childhood Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
335
|
20
|
0.100 |
None |
1.000 |
14 |
|
1999 |
2012 |
Adult Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
332
|
20
|
0.100 |
None |
1.000 |
14 |
|
1999 |
2012 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
13 |
|
1999 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
12 |
|
1999 |
2015 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
644
|
23
|
0.080 |
None |
1.000 |
8 |
|
1999 |
2019 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.060 |
None |
1.000 |
6 |
|
1999 |
2006 |
Juvenile Myelomonocytic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
179
|
70
|
0.030 |
None |
1.000 |
3 |
|
1999 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2015 |
Treatment related acute myeloid leukaemia
|
disease |
|
Neoplastic Process
|
65
|
4
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2011 |
Leukemia, Myelomonocytic, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
158
|
28
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2019 |
acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
|
disease |
|
Neoplastic Process
|
49
|
1
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2003 |
Myelodysplasia
|
disease |
|
Congenital Abnormality
|
181
|
4
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2019 |
Lymphoid leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
288
|
4
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2015 |
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.100 |
None |
1.000 |
17 |
|
2000 |
2016 |
Blast Phase
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
299
|
14
|
0.040 |
None |
1.000 |
4 |
|
2000 |
2011 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.100 |
None |
0.952 |
21 |
|
2001 |
2019 |
Childhood Acute Myeloid Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
215
|
6
|
0.100 |
None |
1.000 |
11 |
|
2001 |
2019 |
Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
365
|
43
|
0.040 |
None |
1.000 |
4 |
|
2001 |
2011 |
M5b Acute differentiated monocytic leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
122
|
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2003 |